[Federal Register: January 28, 1999 (Volume 64, Number 18)]
[Notices]               
[Page 4432]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28ja99-84]


[[Page 4432]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 98N-0148]

 
Open Meeting on World Health Organization Recommendations on 
Ephedrine and Other Substances

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing a public 
meeting concerning recommendations by the World Health Organization 
(WHO) to impose international manufacturing and distributing 
restrictions, under international treaties, on ephedrine and other drug 
substances. The comments received as a result of this public meeting 
will be considered in preparing the U.S. position on these proposals 
for a meeting of the United Nations Commission on Narcotic Drugs (CND) 
in Vienna, Austria, on March 16 through 25, 1999.

DATES:  The public meeting will be held on Friday, February 19, 1999, 
from 9:30 a.m. to 4 p.m. Notifications on participation and/or 
attendance should be submitted by Tuesday, February 16, 1999.

ADDRESSES: The public meeting will be held in Parklawn Bldg., 
conference room C, 5600 Fishers Lane, Rockville, MD 20857.

.FOR FURTHER INFORMATION CONTACT:  Nicholas P. Reuter, Office of Health 
Affairs (HFY-20), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-1696, e-mail ``nreuter@oc.fda.gov''.

    There is no registration fee, however, space is limited. 
Participants and persons interested in attending the public meeting 
should call the contact person listed in this document to register. 
Registrations also may be transmitted by fax to 1-301-443-0232. Please 
include the name and title of the person participating or attending, 
the name of the organization, telephone number, and fax number. An 
agenda and other information will be compiled after February 16, 1999.
SUPPLEMENTARY INFORMATION: In the Federal Register of January 11, 1999 
(64 FR 1629), FDA published a notice announcing the WHO recommendations 
to control substances under international drug control treaties. The 
notice also provided interested persons with the opportunity to submit 
written comments and to request an informal public meeting. In response 
to that notice, FDA received requests for a public meeting. The 
comments received as a part of this public meeting, along with 
information submitted in response to the January 11, 1999, notice will 
be considered in preparing the U.S. position on these proposals for a 
meeting of the CND in Vienna, Austria, on March 16 through 25, 1999.

    Dated: January 22, 1999.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 99-2058 Filed 1-27-99; 8:45 am]
BILLING CODE 4160-01-F